Recent advances in the diagnosis of irritable bowel syndrome

M El-Salhy - Expert Review of Gastroenterology & Hepatology, 2015 - Taylor & Francis
The symptom-based diagnosis of irritable bowel syndrome (IBS) has not been established in
everyday clinical practice, and the diagnosis of this disorder remains one of exclusion. It has …

[HTML][HTML] Densities of rectal peptide YY and somatostatin cells as biomarkers for the diagnosis of irritable bowel syndrome

M El-Salhy, JG Hatlebakk, OH Gilja, T Hausken - Peptides, 2015 - Elsevier
Irritable bowel syndrome (IBS) is a common chronic disorder. IBS diagnosis is a diagnosis of
exclusion since there are no blood tests, radiological or endoscopic examinations for this …

Neuroendocrine Biomarkers of Herbal Medicine for Major Depressive Disorder: A Systematic Review and Meta-Analysis

HB Seung, HJ Kwon, CY Kwon, SH Kim - Pharmaceuticals, 2023 - mdpi.com
Major depressive disorder (MDD) is a medical condition involving persistent sadness and
loss of interest; however, conventional treatments with antidepressants and cognitive …

Metabolic biomarkers in irritable bowel syndrome diagnosis

O Vakili, PA Sedeh, M Pourfarzam - Clinica Chimica Acta, 2024 - Elsevier
Irritable bowel syndrome (IBS) is a chronic gastrointestinal (GI) disorder characterized by
altered bowel habits and abdominal discomfort during defecation. It significantly impacts life …

No increase in prevalence of somatization in functional vs organic dyspepsia: a cross‐sectional survey

DJ Gracie, P Bercik, DG Morgan… - …, 2015 - Wiley Online Library
Background Psychological factors are associated with functional gastrointestinal (GI)
disorders. Literature suggests that somatization is associated with functional dyspepsia (FD) …

Economic living standard and abdominal pain mediate the association between functional gastrointestinal disorders and depression or anxiety

S MH, H PE, K JI, B NK, R NC, T NJ… - Neurogastroenterology …, 2023 - Wiley Online Library
Abstract Background Functional gastrointestinal disorders (FGIDs) are common and cause
significant morbidity. Psychiatric comorbidities associated with FGIDs include anxiety and …

Neuronal‐enriched extracellular vesicles in individuals with IBS: A pilot study of COMT and BDNF

KR Weaver, M Mustapic, D Kapogiannis… - …, 2022 - Wiley Online Library
Background Irritable bowel syndrome (IBS) is characterized by abdominal pain, bowel habit
alterations, and psychiatric comorbidities. Although pathophysiology remains incompletely …

An international Delphi study to assess the need for multiaxial criteria in diagnosis and management of functional gastrointestinal disorders

P Austin, S Henderson, I Power, M Jirwe… - Journal of Psychosomatic …, 2013 - Elsevier
Purpose To assess agreement, consensus, and disagreement between experts in different
domains in the evaluation of functional gastrointestinal disorders (FGIDs). Methods We …

Drug discovery approaches to irritable bowel syndrome

PJ Hornby - Expert opinion on drug discovery, 2015 - Taylor & Francis
Introduction: Irritable bowel syndrome (IBS) is defined by symptoms of abdominal pain and
altered bowel habits without detectable organic disease. Antidepressants and serotonin …

Biomarkers for IBS: ready for prime time?

G Barbara - Nature Reviews Gastroenterology & Hepatology, 2015 - nature.com
Biomarkers for IBS: ready for prime time? | Nature Reviews Gastroenterology & Hepatology
Skip to main content Thank you for visiting nature.com. You are using a browser version with …